Chronic Lymphocytic Leukemia

>

The OncLive Chronic Lymphocytic Leukemia condition center page is a comprehensive resource for clinical news and expert insights on treatment advances and ongoing research in chronic lymphocytic leukemia. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs and updates with chronic lymphocytic leukemia therapy.

Latest News

CLL/SLL | Image Credit: © Oleksandr - stock.adobe.com
Pirtobrutinib Improves Patient-Reported Outcomes in Relapsed/Refractory CLL/SLL

June 16th 2025

PROs were improved with pirtobrutinib among evaluable patient with CLL/SLL treated during the BRUIN CLL-321 trial.

Image Credit: © Bipul Kumar - stock.adobe.com
MAIC Analysis Shows PFS Favorability With Zanubrutinib vs Acalabrutinib/Venetoclax in CLL

June 16th 2025

BGB-16673 in CLL/SLL | Image  Credit: © Om.Nom.Nom -  stock.adobe.com
BGB-16673 Is Safe, Elicits Nearly 85% ORR in Relapsed/Refractory CLL/SLL

June 15th 2025

FDA
FDA Approves Tablet Formulation of Zanubrutinib for B-Cell Malignancies

June 11th 2025

Chronic Lymphocytic Leukemia | Image Credit: © LELISAT - stock.adobe.com
Acalabrutinib-Based Regimens Receive European Approval in Frontline CLL

June 6th 2025

More News